Lactate Metabolism and Signaling in Amyotrophic Lateral Sclerosis
Open Access
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease characterized by the selective degeneration of upper and lower motor neurons (MNs). Although the specific pathogenesis of ALS is not yet fully understood, there is increasing evidence that abnormal energy metabolism plays a key role in the onset and progression of the disease. Lactate has traditionally been considered a metabolic by-product of glycolysis and has received increasing attention in recent years. Research has shown that lactate is not only an important energy substrate but also a signaling molecule that regulates a variety of physiological processes, including neuron-glia metabolic coupling, neuroprotection and inflammatory responses. In ALS, abnormalities in lactate metabolism, dysfunction of the lactate shuttle, and dysregulation of lactate-related signaling pathways may jointly lead to neuronal energy deficits and increased neuroinflammation, thereby promoting MN degeneration. This review summarizes the latest advances in lactate metabolism and lactate-mediated signaling in ALS, with particular emphasis on their roles in neuronal energy regulation, neuroprotection and inflammatory regulation. In addition, we also discuss potential therapeutic strategies for lactate metabolism and its related pathways, aiming to provide new insights into the pathogenesis of ALS and the development of treatment methods for lactate-related metabolism.Keywords
Funding Information
- National Natural Science Foundation of China (82571627)
- National Natural Science Foundation of China (82271483)
- Shandong Province Natural Science Foundation of China (ZR2024MH112)
- Shandong Provincial Medical and Health Science and Technology Development Plan (202402010641)
This publication has 170 references indexed in Scilit:
- Blood Lactate as a Prognostic Biomarker for Survival and Weight Loss in Amyotrophic Lateral Sclerosis: An Exploratory–Validation StudyAnnals of Neurology, 2026
- C9orf72 Repeat Expansion Induces Metabolic Dysfunction in Human iPSC ‐Derived Microglia and Modulates Glial‐Neuronal CrosstalkGlia, 2025
- Disrupted function of lactate transporter MCT1, but not MCT4, in Schwann cells affects the maintenance of motor end‐plate innervationGlia, 2020
- Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisAnnals of Neurology, 2019
- Running and swimming prevent the deregulation of the BDNF/TrkB neurotrophic signalling at the neuromuscular junction in mice with amyotrophic lateral sclerosisCellular and Molecular Life Sciences, 2019
- Energy metabolism in ALS: an underappreciated opportunity?Acta Neuropathologica, 2018
- Wildtype motoneurons, ALS‐Linked SOD1 mutation and glutamate profoundly modify astrocyte metabolism and lactate shuttlingGlia, 2017
- The monocarboxylate transporter family—Role and regulationIUBMB Life, 2011
- PGC‐1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse modelMuscle & Nerve, 2011
- Identification of a Unique Monocarboxylate Transporter (MCT3) in Retinal Pigment EpitheliumBiochemical and Biophysical Research Communications, 1997